Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical

  • Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
    You have access
    Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
    Wolfgang P. Fendler, Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R. Flavell, Spencer C. Behr, I-Wei K. Wu, Courtney Lawhn-Heath, Miguel H. Pampaloni, Robert E. Reiter, Matthew B. Rettig, Jeannine Gartmann, Vishnu Murthy, Roger Slavik, Peter R. Carroll, Ken Herrmann, Jeremie Calais and Thomas A. Hope
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1793-1799; DOI: https://doi.org/10.2967/jnumed.120.242180
  • CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma
    You have access
    CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma
    Peter Herhaus, Jana Lipkova, Felicitas Lammer, Igor Yakushev, Tibor Vag, Julia Slotta-Huspenina, Stefan Habringer, Constantin Lapa, Tobias Pukrop, Dirk Hellwig, Benedikt Wiestler, Andreas K. Buck, Martina Deckert, Hans-Jürgen Wester, Florian Bassermann, Markus Schwaiger, Wolfgang Weber, Björn Menze and Ulrich Keller
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1765-1771; DOI: https://doi.org/10.2967/jnumed.120.241703
  • You have access
    Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study
    Thorsten Derlin, Rudolf A. Werner, Marcel Lafos, Christoph Henkenberens, Christoph A.J. von Klot, Jan M. Sommerlath Sohns, Tobias L. Ross and Frank M. Bengel
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1602-1606; DOI: https://doi.org/10.2967/jnumed.120.241588
  • Prognostic Value of <sup>18</sup>F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy
    You have access
    Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy
    Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni and Richard P. Baum
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1560-1569; DOI: https://doi.org/10.2967/jnumed.119.241414
  • You have access
    PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune–Albright Syndrome, a Genetic Mosaic Disorder
    Lora D. Weidner, Yuichi Wakabayashi, Louise A. Stolz, Michael T. Collins, Lori Guthrie, Milalynn Victorino, Joyce Chung, William Miller, Sami S. Zoghbi, Victor W. Pike, Masahiro Fujita, Robert B. Innis and Alison M. Boyce
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1672-1677; DOI: https://doi.org/10.2967/jnumed.120.241976
  • Data-Driven Respiratory Gating Outperforms Device-Based Gating for Clinical <sup>18</sup>F-FDG PET/CT
    You have access
    Data-Driven Respiratory Gating Outperforms Device-Based Gating for Clinical 18F-FDG PET/CT
    Matthew D. Walker, Andrew J. Morgan, Kevin M. Bradley and Daniel R. McGowan
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1678-1683; DOI: https://doi.org/10.2967/jnumed.120.242248
  • First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
    You have access
    First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
    Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael J. Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, Wolfgang A. Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson and Mark P.S. Dunphy
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1580-1587; DOI: https://doi.org/10.2967/jnumed.119.234864
  • <sup>18</sup>F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume
    You have access
    18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume
    James C. Reynolds, Roberto Maass-Moreno, Anish Thomas, Alexander Ling, Emerson B. Padiernos, Seth M. Steinberg and Raffit Hassan
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1570-1575; DOI: https://doi.org/10.2967/jnumed.119.238733
  • The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer Patients
    You have access
    The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients
    Elliot M. Abbott, Nadia Falzone, Boon Q. Lee, Christiana Kartsonaki, Helen Winter, Tessa A. Greenhalgh, Daniel R. McGowan, Nigar Syed, Ana M. Denis-Bacelar, Philip Boardman, Ricky A. Sharma and Katherine A. Vallis
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1658-1664; DOI: https://doi.org/10.2967/jnumed.119.233650
  • Confirmation of <sup>123</sup>I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
    You have access
    Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
    Daniela D. Maltais, Lennon G. Jordan, Hoon-Ki Min, Toji Miyagawa, Scott A. Przybelski, Timothy G. Lesnick, Robert R. Reichard, Dennis W. Dickson, Melissa E. Murray, Kejal Kantarci, Bradley F. Boeve and Val J. Lowe
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1628-1635; DOI: https://doi.org/10.2967/jnumed.119.239418

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 62
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire